DK1455799T3 - Farmaceutiske kombinationer af adenosin A-2A- og beta-2-adrenerge receptoragonister - Google Patents

Farmaceutiske kombinationer af adenosin A-2A- og beta-2-adrenerge receptoragonister

Info

Publication number
DK1455799T3
DK1455799T3 DK02785778T DK02785778T DK1455799T3 DK 1455799 T3 DK1455799 T3 DK 1455799T3 DK 02785778 T DK02785778 T DK 02785778T DK 02785778 T DK02785778 T DK 02785778T DK 1455799 T3 DK1455799 T3 DK 1455799T3
Authority
DK
Denmark
Prior art keywords
adenosine
beta
receptor agonists
adrenergic receptor
pharmaceutical combinations
Prior art date
Application number
DK02785778T
Other languages
Danish (da)
English (en)
Inventor
Michael Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK1455799T3 publication Critical patent/DK1455799T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DK02785778T 2001-12-06 2002-11-28 Farmaceutiske kombinationer af adenosin A-2A- og beta-2-adrenerge receptoragonister DK1455799T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0129270.5A GB0129270D0 (en) 2001-12-06 2001-12-06 Pharmaceutical combination
PCT/IB2002/005057 WO2003047598A1 (fr) 2001-12-06 2002-11-28 Combinaisons pharmaceutiques d'agonistes du recepteur a-2a de l'adenosine et du recepteur beta 2 adrenergique
EP02785778A EP1455799B1 (fr) 2001-12-06 2002-11-28 Combinaisons pharmaceutiques d'agonistes du recepteur a-2a de l'adenosine et du recepteur beta 2 adrenergique

Publications (1)

Publication Number Publication Date
DK1455799T3 true DK1455799T3 (da) 2005-06-27

Family

ID=9927164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02785778T DK1455799T3 (da) 2001-12-06 2002-11-28 Farmaceutiske kombinationer af adenosin A-2A- og beta-2-adrenerge receptoragonister

Country Status (38)

Country Link
EP (1) EP1455799B1 (fr)
JP (1) JP2005513041A (fr)
KR (1) KR100685557B1 (fr)
CN (1) CN1856314A (fr)
AP (2) AP2004003053A0 (fr)
AR (1) AR037634A1 (fr)
AT (1) ATE293982T1 (fr)
AU (1) AU2002351066B2 (fr)
BR (1) BR0214998A (fr)
CA (1) CA2469085A1 (fr)
CO (1) CO5580752A2 (fr)
DE (1) DE60203934T2 (fr)
DK (1) DK1455799T3 (fr)
EA (1) EA200400639A1 (fr)
EC (1) ECSP045132A (fr)
ES (1) ES2239728T3 (fr)
GB (1) GB0129270D0 (fr)
GT (1) GT200200258A (fr)
HN (1) HN2002000348A (fr)
HR (1) HRP20040517A2 (fr)
HU (1) HUP0402540A3 (fr)
IS (1) IS7280A (fr)
MA (1) MA27150A1 (fr)
MX (1) MXPA04005506A (fr)
NO (1) NO20042839L (fr)
NZ (1) NZ533054A (fr)
OA (1) OA12738A (fr)
PA (1) PA8560701A1 (fr)
PE (1) PE20030834A1 (fr)
PL (1) PL370739A1 (fr)
PT (1) PT1455799E (fr)
PY (1) PY0228254A (fr)
SV (1) SV2004001426A (fr)
TN (1) TNSN04101A1 (fr)
TW (1) TWI256388B (fr)
UY (1) UY27566A1 (fr)
WO (1) WO2003047598A1 (fr)
ZA (1) ZA200403966B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100785969B1 (ko) * 2004-05-12 2007-12-14 동아제약주식회사 Ｆｇｆ2를 유효성분으로 포함하는 천식 및 만성폐쇄성폐질환 예방 또는 치료제
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
CN105473133A (zh) 2013-04-30 2016-04-06 欧缇托匹克公司 干粉制剂及使用方法
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
CA3076353A1 (fr) 2017-09-22 2019-03-28 Otitopic Inc. Compositions de poudre seche contenant du stearate de magnesium
JPWO2022050230A1 (fr) * 2020-09-03 2022-03-10

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003960D0 (en) * 2000-02-18 2000-04-12 Pfizer Ltd Purine derivatives
TWI227240B (en) * 2000-06-06 2005-02-01 Pfizer 2-aminocarbonyl-9H-purine derivatives

Also Published As

Publication number Publication date
AU2002351066B2 (en) 2007-10-18
PT1455799E (pt) 2005-08-31
ES2239728T3 (es) 2005-10-01
PE20030834A1 (es) 2003-10-08
DE60203934D1 (de) 2005-06-02
TWI256388B (en) 2006-06-11
ECSP045132A (es) 2004-07-23
ATE293982T1 (de) 2005-05-15
PA8560701A1 (es) 2004-05-07
BR0214998A (pt) 2004-12-28
AP2004003082A0 (en) 2004-09-30
GT200200258A (es) 2003-08-22
DE60203934T2 (de) 2006-02-23
PY0228254A (es) 2004-06-01
AR037634A1 (es) 2004-11-17
KR100685557B1 (ko) 2007-02-22
TNSN04101A1 (fr) 2006-06-01
CN1856314A (zh) 2006-11-01
HN2002000348A (es) 2005-02-04
WO2003047598A1 (fr) 2003-06-12
CO5580752A2 (es) 2005-11-30
IS7280A (is) 2004-05-21
AU2002351066A1 (en) 2003-06-17
EP1455799A1 (fr) 2004-09-15
JP2005513041A (ja) 2005-05-12
UY27566A1 (es) 2003-07-31
AP2004003053A0 (en) 2004-06-30
HUP0402540A3 (en) 2008-04-28
MA27150A1 (fr) 2005-01-03
NZ533054A (en) 2007-02-23
OA12738A (en) 2006-06-29
EA200400639A1 (ru) 2004-12-30
MXPA04005506A (es) 2004-12-10
TW200300759A (en) 2003-06-16
GB0129270D0 (en) 2002-01-23
EP1455799B1 (fr) 2005-04-27
KR20050044697A (ko) 2005-05-12
NO20042839L (no) 2004-07-05
SV2004001426A (es) 2004-05-07
ZA200403966B (en) 2005-06-22
CA2469085A1 (fr) 2003-06-12
HRP20040517A2 (en) 2004-10-31
PL370739A1 (pl) 2005-05-30
HUP0402540A2 (hu) 2005-07-28

Similar Documents

Publication Publication Date Title
ATE430124T1 (de) Arylanilin beta-2 adrenergische rezeptor agoniste
ATE273989T1 (de) Adenosin a1-rezeptor agonisten
DE69815378D1 (de) Adenosin a1-rezeptor agonisten
ATE273990T1 (de) Adenosin a1-rezeptor agonisten
ATE293627T1 (de) Adenosin a2a rezeptor antagonisten
DK1261322T3 (da) Farmaceutiske sammensætninger omfattende en adenosinreceptoragonist eller antagonist
DE60209251D1 (de) Adenosine a2a receptor antagonisten
EE200300191A (et) Alfa-arüül-etanoolamiinid ja nende kasutamine beeta-3 adrenergiliste retseptorite agonistidena
ATE448238T1 (de) 3-beta-d-ribofuranosylthiazolo(4,5- delta)pyridimin-nucleoside und ihre verwendung
EE200400025A (et) 5-HT retseptori ligandid ja nende kasutamine
ATE256141T1 (de) N-pyrazol a2a rezeptor agonisten
ATE240341T1 (de) C-pyrazol a2a rezeptor agonisten
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
DK1687257T3 (da) Aminosubstituerede ethylaminoagonister af den beta2-adrenerge receptor
PT1237559E (pt) Combinacoes farmaceuticas compreendendo um antagonista do receptor p2t e megalatrano
PT1208100E (pt) Antagonistas selectivos de receptores de adenosina a2b
DE60204749D1 (de) Abtast- und Halteschaltung
NO20035300D0 (no) Aminokinolin- og aminopyridinderivater og deres anvendelse som adenosin A<N>3-ligander
PT1455799E (pt) Combinacoes farmaceuticas de agonistas de receptores a-2a de adenosina e adrenergicos beta-2
ATE250621T1 (de) Oral aktive a1 adenosin rezeptor agonisten
ID30476A (id) Plaster berbasis elemen struktural yang dipra-fabrikasi, dan khususnya plaster berbasis papan, yang mempunyai ketahanan api yang diperbaiki
PT1448566E (pt) Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
CL2004000761A1 (es) Compuestos derivados de benzotiazol sustituidos con dioxano, ligandos de receptores de adenosina, con afinidad con los receptores a2a, a1 y a3; composicion farmaceutica; procedimiento de preparacion; y uso de los compuestos en el tratamiento de la re
DE60220713D1 (de) Ribofuranosyluronamid Derivate als Kristall; ein menschlicher Adenosin A2A Rezeptor Agonsit
IS7277A (is) Samsetning kjörvíss PDE4 hindra og adrenergísks beta-2 viðtaka gerandefnis